# Comparing NicoBloc to Nicotine Lozenges

> **NCT03720899** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 45 (actual)

## Conditions studied

- Smoking Cessation
- Nicotine Dependence

## Interventions

- **DRUG:** NicoBloc
- **DRUG:** Nicotine Lozenge

## Key facts

- **NCT ID:** NCT03720899
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-21
- **Primary completion:** 2021-01-03
- **Final completion:** 2021-03-03
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03720899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03720899, "Comparing NicoBloc to Nicotine Lozenges". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03720899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*